SCHEMBL31011007

SCHEMBL31011007

Fc1ccc(Nc2ccccn2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
MAPK10 P53779 1/20 0.53
GFER P55789 1/20 0.53
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
MAPK1 P28482 1/20 0.46
JAK2 O60674 2/20 0.46
JAK1 P23458 2/20 0.46
TYK2 P29597 2/20 0.46
STAT3 P40763 1/20 0.46
JAK3 P52333 1/20 0.46
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
ALOX12 P18054 1/20 0.45
HTT P42858 1/20 0.45
KLF5 Q13887 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15649981 1.00 KMT2A (0.53) KMT2AMEN1MAPK10GFERRAB9A
SCHEMBL20385536 0.85 MKNK1 (0.51) KMT2AMEN1RAB9ANPC1JAK2
Hydrochloric Acid SCHEMBL4901670 0.83 TP53 (0.47) KMT2AMEN1MAPK10GFERRAB9A
SCHEMBL26910995 0.81 KMT2A (0.64) KMT2AMEN1MAPK10GFERRAB9A
SCHEMBL221242 0.81 KMT2A (0.76) KMT2AMEN1MAPK10GFERRAB9A
SCHEMBL29391624 0.81 KMT2A (0.76) KMT2AMEN1MAPK10GFERRAB9A
SCHEMBL30541040 0.81 MEN1 (0.53) KMT2AMEN1MAPK10GFERRAB9A
SCHEMBL3266384 0.80 MEN1 (0.52) KMT2AMEN1MAPK10GFERJAK2
SCHEMBL16245640 0.79 ALDH1A1 (0.51) KMT2AMEN1MAPK10MAPK1JAK2
SCHEMBL6574416 0.79 KMT2A (0.73) KMT2AMEN1MAPK10GFERRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787142-B Compounds as cyclin dependent kinase 9 inhibitors and uses thereof 石药集团中奇制药技术(石家庄)有限公司 2024-08-02 CN disclosed